Who owns ASCENTAGE PHARMA GROUP INTL?
- Ticker: AAPG
- CUSIP Number: 04390b105
Tip: Access positions for across all investors
Analyze quarterly positions in Ascentage Pharma Group Intl with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ascentage Pharma Group Intl stock
Who bought or sold ASCENTAGE PHARMA GROUP INTL this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Point72 Asset Management | 16k | $383k | -4% | Mar 2026 |
|
| XY Capital | 13k | $311k | -5% | Mar 2026 |
|
| Morgan Stanley | 498.00 | $12k | 225% | Mar 2026 |
|
| Tower Research Capital | 230.00 | $6.0k | -72% | Dec 2025 |
|
| Advisor Group Holdings | 220.00 | $5.8k | 0% | Dec 2025 |
|
| UBS Group | 124.00 | $3.0k | -97% | Mar 2026 |
|
| EverSource Wealth Advisors | 24.00 | $573.000000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 6.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Ascentage Pharma Group Intl?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 9.7k | $255k |
| Mirae Asset Global Investments | Dec 2025 | 2.5k | $67k |
| Bell Investment Advisors | Dec 2025 | 67.00 | $1.8k |